SCHEMBL4558351

SCHEMBL4558351

O=C(O)CCCCCCCCCCCCCC1C=CCC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.63
TDP1 Q9NUW8 4/20 0.63
ALOX15 P16050 2/20 0.63
USP2 O75604 1/20 0.63
TSHR P16473 5/20 0.45
LMNA P02545 3/20 0.45
HSD17B10 Q99714 3/20 0.45
PMP22 Q01453 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
CYP2C9 P11712 1/20 0.45
NR1I2 O75469 1/20 0.45
POLB P06746 1/20 0.45
THRB P10828 1/20 0.45
ACHE P22303 1/20 0.45
APEX1 P27695 1/20 0.45
RECQL P46063 1/20 0.45
BLM P54132 1/20 0.45
SAE1 Q9UBE0 1/20 0.45
UBA2 Q9UBT2 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29517121 1.00 ALDH1A1 (0.63) ALDH1A1TDP1ALOX15USP2TSHR
Chaulmoogric Acid SCHEMBL560850 1.00 ALDH1A1 (0.63) ALDH1A1TDP1ALOX15USP2TSHR
Chaulmoogric Acid SCHEMBL560848 1.00 ALDH1A1 (0.63) ALDH1A1TDP1ALOX15USP2TSHR
SCHEMBL580438 1.00 ALDH1A1 (0.63) ALDH1A1TDP1ALOX15USP2TSHR
Chaulmoogric Acid SCHEMBL560849 1.00 ALDH1A1 (0.63) ALDH1A1TDP1ALOX15USP2TSHR
SCHEMBL2491883 1.00 ALDH1A1 (0.63) ALDH1A1TDP1ALOX15USP2TSHR
SCHEMBL580439 1.00 ALDH1A1 (0.63) ALDH1A1TDP1ALOX15USP2TSHR
SCHEMBL2494531 1.00 ALDH1A1 (0.63) ALDH1A1TDP1ALOX15USP2TSHR
SCHEMBL17540730 0.98 ALDH1A1 (0.60) ALDH1A1TDP1ALOX15USP2TSHR
Chaulmoogric Acid SCHEMBL15865192 0.95 ALDH1A1 (0.62) ALDH1A1TDP1ALOX15USP2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090209485-A1 MODULATING ANGIOGENESIS WITH NOD FACTORS SUCH AS GLUCOSAMINE OLIGOSACCHARIDES PARISH CHRISTOPHER RICHARD 2009-08-20 US disclosed
EP-1871392-A1 MODULATING ANGIOGENESIS WITH NOD FACTORS SUCH AS GLUCOSAMINE OLIGOSACCHARIDES Parish, Christopher Richard (AU) 2008-01-02 EP disclosed
WO-2006102717-A1 MODULATING ANGIOGENESIS WITH NOD FACTORS SUCH AS GLUCOSAMINE OLIGOSACCHARIDES PARISH CHRISTOPHER RICHARD (AU) 2006-10-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209485-A1 MODULATING ANGIOGENESIS WITH NOD FACTORS SUCH AS GLUCOSAMINE OLIGOSACCHARIDES FLT4, UGGT1, FLT1 ALDH1A1 4316/4885TDP1 4292/4885ALOX15 2466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.